Meticulous Research®, a prominent global market research firm, has published a detailed report titled “Pharmaceutical Packaging Market by Material (Polymer [PE, PP, PET], Glass, Paper, Metal), Type (Bottles, Blister, PFS, Caps, Vials, Ampoules, Sachet, Inhaler, Secondary, Tertiary), Dosage Form (Oral, Parenteral, Topical), End User - Global Forecast to 2031.”

The report forecasts that the global pharmaceutical packaging market will reach $176.54 billion by 2031, with a compound annual growth rate (CAGR) of 7.6% from 2024 to 2031. This growth is fueled by the expansion of the pharmaceutical sector, increasing demand for drug delivery devices, rising healthcare expenditures, a focus on biosimilars, a trend towards contract manufacturing and packaging, and an aging population with a higher prevalence of chronic diseases. Despite these growth drivers, challenges such as counterfeit packaging, waste from single-use products, and concerns about material safety could hinder market progress.

Opportunities for growth are highlighted by the rising adoption of personalized medicines and self-medication, improving healthcare systems in emerging markets, increased pharmaceutical R&D spending, and a focus on vaccine development. However, evolving regulatory requirements and changing market dynamics pose significant challenges.

Download Free Research PDF @ https://www.meticulousresearch.com/download-sample-report/cp_id=5298

Key Market Players
Prominent companies in the pharmaceutical packaging sector include Amcor plc (Switzerland), AptarGroup, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Gerresheimer AG (Germany), Schott Pharma AG & Co. KGaA (Germany), Berry Global Group, Inc. (U.S.), Drug Plastics Group (U.S.), Catalent, Inc. (U.S.), SGD Pharma (France), Corning Inc. (U.S.), WestRock Company (U.S.), and West Pharmaceutical Services, Inc. (U.S.).

Market Segmentation and Insights
The report segments the market by material (Polymer, Glass, Paper & Paperboard, Metal, and Other Materials), packaging type (Primary, Secondary, Tertiary), dosage form (Oral, Parenteral, Other), and end user (Pharmaceutical Companies, Contract Companies, Pharmacies).
• Materials: The glass segment is expected to experience the highest CAGR due to increased use in pharmaceutical packaging, rising demand for vials and ampoules, and recent innovations in glass packaging. For example, Stoelzle Pharma (Austria) launched a new PharmaCos packaging line featuring a variety of glass jars in October 2023.
• Packaging Types: Primary packaging is forecasted to dominate the market in 2024, driven by advancements such as RFID integration, temperature-indicating inks, and NFC technologies.
• Dosage Forms: The parenteral dosage form segment is projected to grow the fastest, propelled by the development of sophisticated drug delivery devices like pre-filled syringes and advancements in smart packaging.
• End Users: The pharmaceutical companies segment is anticipated to hold the largest share in 2024, driven by the rising demand for medicines, increasing chronic disease prevalence, and a growing number of drugs in development.

Quick Buy – Pharmaceutical Packaging Market - Global Opportunity Analysis and Industry Forecast (2024-2031), Research Report: https://www.meticulousresearch.com/Checkout/28241997

Geographic Analysis
The report covers major regions, including North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. Asia-Pacific is expected to achieve the highest CAGR, with China leading the region due to increased pharmaceutical R&D investments and government initiatives like the Made in China (MIC) 2025 plan to boost domestic manufacturing capabilities.

Contact Us:
Meticulous Research®
Email- [email protected]
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research